Mark D. Stegall, M.D., is a transplant surgeon with the Kidney and Pancreas Transplant Programs within the Transplant Center at Mayo Clinic in Rochester, MN. Outside of his clinical practice his primary research goals are to improve the long-term outcomes of kidney transplant recipients and to develop new therapies to block the body from forming antibodies against the transplanted kidney.